Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 22/09/2008

    Controlled suicide

    Professor Dr. Christoph Borner from the University of Freiburg and his team are investigating the molecular mechanisms of apoptosis. Their research also provides insights into the medical treatment of cells that do not want to die - cancer cells.

    https://www.gesundheitsindustrie-bw.de/en/article/news/controlled-suicide
  • Article - 21/09/2008

    Prize for improved leukaemia therapy

    The German Society for Medical Physics DGMP has awarded its science prize to the medical physicist Gerhard Glatting for his research into the specific irradiation of tumour tissue using radioactively labelled antibodies.

    https://www.gesundheitsindustrie-bw.de/en/article/news/prize-for-improved-leukaemia-therapy
  • Press release - 17/09/2008

    varionostic to develop test for detecting mutations of the K-RAS gene

    The test detects K-RAS mutations and could be an additional tool for targeted therapies of patients with colorectal cancer who stand to benefit from newly developed cancer therapies that rely on the genotype of the K-RAS oncogene.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/varionostic-to-develop-test-for-detecting-mutations-of-the-k-ras-gene
  • Article - 16/09/2008

    New opportunities for the MedCare TechArea

    Although the MedCare TechArea was not one of the five top clusters to recently receive an award from the German Federal Ministry of Education and Research the cluster and its MedCare TechArea will be further developed.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-opportunities-for-the-medcare-techarea
  • Press release - 14/09/2008

    Relaunch of www. research-in-germany.de

    This internet portal an initiative of the German Federal Ministry of Education and Research provides foreign researchers and scientists with a wealth of easily accessible information about research opportunities in Germany.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/relaunch-of-www-research-in-germany-de
  • Press release - 13/09/2008 You see a 50 Euro note and the catchword "wissen" (knowledge) in a german dictionary.

    Transform ideas into successful companies

    With Science2Start - targeted promotion and support of start-up companies in the life sciences sector BioRegio STERN Management GmbH is keen to set new companies on course for success.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/transform-ideas-into-successful-companies
  • Article - 10/09/2008

    Patients with rare diseases benefit from European research networks

    In some types of spinocerebellar ataxia and spastic paraplegia the number of people affected is so small that the search for the causes of the disease seems to be an almost hopeless endeavour. Human geneticist Prof. Dr. Olaf Rieß and neurologist Prof. Dr. Ludger Schöls from the University Hospital Tübingen are now hoping to promote research and improve the medical treatment of such patients with the aid of two new European networks.

    https://www.gesundheitsindustrie-bw.de/en/article/news/patients-with-rare-diseases-benefit-from-european-research-networks
  • Article - 08/09/2008

    Research increases hope

    Duchenne muscular dystrophy DMD is a severe disease affecting boys characterised by rapid progression of muscle degeneration so that boys as young as 10 to 12 years of age have to use a wheelchair and leading to death in young men. In Germany about 2500 children and young adults suffer from DMD.

    https://www.gesundheitsindustrie-bw.de/en/article/news/research-increases-hope
  • Press release - 05/09/2008

    Thomas U. Mayer - research for aesthetes

    Mayers major interest is cell division which he sees as an interesting and also a beautiful aesthetic process. Prof. Dr. Thomas U. Mayer occupies the chair of molecular genetics at the University of Constance where he enjoys working in close contact with colleagues from the field of chemistry.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/thomas-u-mayer-research-for-aesthetes
  • Press release - 04/09/2008

    Rhine Neckar Biotechnology Cluster wins German Top Cluster Contest

    The Rhine-Neckar biotechnology cluster BioRN was distinguished as one of the five most significant high-tech regions in Germany and will receive part of the 200 million Euro federal grant.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/rhine-neckar-biotechnology-cluster-wins-german-top-cluster-contest
  • Article - 02/09/2008

    Screening with high quality and high throughput

    The Early Discovery department of the research-based pharmaceutical company Nycomed GmbH deals with early drug research from the identification of targets to the generation of lead structures. This process involves high-throughput drug screening. On behalf of www.bio-pro.de Michael Statnik talked with Dr. Stefanie Polej about the process of the automated analysis of molecule activities in the Constance-based company.

    https://www.gesundheitsindustrie-bw.de/en/article/news/screening-with-high-quality-and-high-throughput
  • Press release - 02/09/2008 Portrait of Professor Elke Guenther

    Elke Guenther: inspired by basic research and application-oriented

    The biologist Prof. Dr. Elke Guenther is head of the Department of Electrophysiology at the NMI where her work involves safety pharmacology the development of biosensors and the characterisation of ion channels in the cell membranes in a broad range of different organ systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/elke-guenther-inspired-by-basic-research-and-application-oriented
  • Press release - 31/08/2008

    Genetic tests only by consent

    The German Federal Cabinet agreed on a draft bill on human genetic testing Gene Diagnostics Law. The law protects people against the danger of potential discrimination that could result from knowledge of the genetic properties of individuals. The draft bill prohibits secret tests to determine parentage.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/genetic-tests-only-by-consent
  • Article - 31/08/2008

    Resistance against chemotherapeutics

    Many cancers are difficult to treat with drugs because they are resistant to them. A research group at Heidelberg is investigating the molecular mechanisms of multidrug resistance and has the goal to improve the treatment of cancer patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/resistance-against-chemotherapeutics
  • Article - 30/08/2008

    Helpful toxins

    Sometimes a few nanogrammes of toxin are all that is needed to kill someone. Prof. Dr. Dr. Klaus Aktories from the Institute of Experimental and Clinical Pharmacy at the University of Freiburg is investigating why some bacterial toxins are so extremely toxic. Together with his team of researchers Aktories has identified the molecular mechanism of action of Clostridium difficile toxins.

    https://www.gesundheitsindustrie-bw.de/en/article/news/helpful-toxins
  • Article - 30/08/2008

    Plant viruses: Summer School teaches diagnosis and analysis

    Researchers at the University of Stuttgart are leaders in the field of diagnosis and analysis of plant viruses. In a two-week Summer School the researchers imparted their knowledge to virologists from all over the world.

    https://www.gesundheitsindustrie-bw.de/en/article/news/plant-viruses-summer-school-teaches-diagnosis-and-analysis
  • Press release - 28/08/2008

    Günther Schütz and the regulation of gene expression by nuclear receptors

    Professor Dr. Günther Schützs work on the cell- and development-specific gene regulation using nuclear receptors has led amongst other things to new insights into the steroid hormone-dependent early development and differentiation of the nervous system the molecular mechanisms of learning and the development and regulation of drug addiction. Schütz has now been appointed Helmholtz professor which will enable him to continue his work beyond…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/guenther-schuetz-and-the-regulation-of-gene-expression-by-nuclear-receptors
  • Dossier - 28/08/2008 Scheme of Liver cell therapy of cytonet

    Orphan drugs: medicine for the treatment of severe diseases

    Orphan drugs are drugs for the treatment of rare but severe diseases. Since the number of patients who need such drugs is very small the pharmaceutical industry has naturally been reluctant to develop drugs for the treatment of rare diseases. Therefore the development off orphan drugs is supported by the state including a simplified approval procedure and an exclusive right to sell them for a period of ten years.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/orphan-drugs-medicine-for-the-treatment-of-severe-diseases
  • Article - 26/08/2008

    Regulation through protein degradation

    Proteins that are involved in the development of an organism must be activated at the right time and then inactivated if no longer required. Scientists in Tübingen investigate the specific degradation of these proteins through specialised and highly selective systems of the cell.

    https://www.gesundheitsindustrie-bw.de/en/article/news/regulation-through-protein-degradation
  • Article - 26/08/2008

    Gregor Mirow new CEO of greenovation

    The primary objective of greenovation Biotech GmbH is the implementation of a stable production platform for the manufacture of glycoproteins for industrial pharmaceutical applications in accordance with GMP guidelines. Now Gregor Mirow succeeds Hans Bodo Hartmann as the new managing director.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/gregor-mirow-new-ceo-of-greenovation
  • Article - 25/08/2008

    Hartmann continues to grow profitably

    Heidenheim-based Hartmann Group further accelerated its growth in the first six months of 2008. The company reports a growth in sales revenues to 678.5 million euros up 7.4 and increased its consolidated operating net income by 22.1 to 22.5 million euros. The greatest growth was achieved by the Operating Theatre Management segment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/hartmann-continues-to-grow-profitably
  • Press release - 25/08/2008

    Successful liver cell therapy in newborns

    Cytonet GmbH & Co. KG, Germany’s leading cell therapy company, has provided the first clear evidence for the efficacy of its liver cell therapy in severe congenital metabolic disorders of newborns. The study was conducted in cooperation with the University Children’s Hospital in Heidelberg.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/successful-liver-cell-therapy-in-newborns
  • Article - 25/08/2008 import_03396_de.jpg

    Markers that reveal the correct biological age

    Researchers at the University of Ulm have just identified a number of proteins that reveal the biological age of a person. These biomarkers might be used in medical applications to adapt the medical treatment of older people to their individual biological age.

    https://www.gesundheitsindustrie-bw.de/en/article/news/markers-that-reveal-the-correct-biological-age
  • Press release - 25/08/2008

    Cross-border fight against cancer

    The Lake Constance region offers a broad range of cancer therapies and is home to several institutes and companies that are dealing with cancer research. The BioLAGO biotechnology network offers them a joint platform for co-operation and exchange of information.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/cross-border-fight-against-cancer
  • Article - 25/08/2008

    Rare kidney tumour leads the way to a new cancer therapy

    Renal cell carcinoma is a rare disease. In addition, the disease is difficult to treat, and the majority of pharmaceutical companies find the development of new drugs for its treatment too financially risky. Their argument: the market is too small to make up for the high development costs. The Tübingen biotech company immatics was courageous enough to do so and will now be rewarded. The immatics scientists have developed a therapy that not only…

    https://www.gesundheitsindustrie-bw.de/en/article/news/rare-kidney-tumour-leads-the-way-to-a-new-cancer-therapy

Page 105 / 119

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 119
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2023
Website address: https://www.gesundheitsindustrie-bw.de/en/search